Zoetis Inc. (0M3Q.L)

169.68 -2.46 (-1.43%) At close: 06:50PM BST

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com

Sector(s): 
Industry: 
Full Time Employees: 14,100

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Kristin C. Peck	CEO & Director	3.54M	5.2M	1971
Mr. Wetteny N. Joseph	Executive VP & CFO	1.6M	N/A	1972
Ms. Wafaa Mamilli	EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health	1.36M	N/A	1967
Ms. Heidi C. Chen	Employee Advisor	1.24M	N/A	1967
Dr. Robert J. Polzer Ph.D.	Executive VP and President of Research & Development	1.18M	54.13k	1969
Mr. Steven Frank	Vice President of Investor Relations	N/A	N/A	N/A
Ms. Roxanne Lagano	Executive VP, General Counsel & Corporate Secretary	N/A	N/A	1965
Mr. William Price	VP & Chief Communications Officer	N/A	N/A	N/A
Ms. Jeannette Ferran Astorga	Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer	N/A	N/A	1975
Mr. Nick Ashton	Executive VP and President of Global Manufacturing & Supply	N/A	N/A	1973

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate Governance

Zoetis Inc.’s ISS Governance QualityScore as of June 1, 2024 is 3. The pillar scores are Audit: 6; Board: 1; Shareholder Rights: 7; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.